David Rutkowski represents clients in litigation and arbitrations throughout the United States, including commercial and contractual disputes and claims relating to unfair trade practices, products liability, toxic torts, RICO, trade secrets misappropriation, and trademark and copyright infringement.
David has represented clients in the automotive, construction, oil and gas, solar, pharmaceutical, medical device, semiconductor manufacturing, software services, and entertainment industries. His recent representations include: ICC arbitration of claims for breach of contract, unfair trade practices, and breach of competition laws in jurisdictions throughout Asia, Europe, and North America relating to a manufacturing joint venture; breach of contract litigation against members of the supply chain of a medical device manufacturer; and defense of a supplier of construction components involving the destruction of a commercial office building. He also has represented members of the solar industry on supply chain and product liability issues.
David was trial counsel for Wyeth Pharmaceuticals in nationwide products liability litigation involving Wyeth's antidepressant drug, Effexor, earning a unanimous defense verdict against wrongful death claims — the first case of its kind against the antidepressant industry to go to trial in more than six years. He also defended IBM in cases brought by more than 200 current and former employees alleging adverse health effects due to workplace chemical exposure and was part of the team that earned unanimous jury verdicts for IBM in these matters. In addition, he defends other semiconductor manufacturers against similar allegations that workplace exposures resulted in birth defects in the children of former employees.
- University of Notre Dame (J.D. magna cum laude 1996; Journal of Law, Ethics and Public Policy; Thomas J. White Scholar); Stanford University (A.B. 1993)
- California, Michigan, and District of Columbia